Michael Wasserman
Consultant / Advisor at H.I.G. BioHealth Partners LLC
Michael Wasserman active positions
Companies | Position | Start | End |
---|---|---|---|
H.I.G. BioHealth Partners LLC
H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners LLC (H.I.G. BioHealth Partners) is a private equity and venture capital subsidiary of H.I.G. Ventures LLC founded in 1993. The firm is headquartered in Miami, Florida with additional offices around the globe. | Consultant / Advisor | 01/05/2021 | - |
Private Equity Investor | 01/01/2004 | - |
Career history of Michael Wasserman
Former positions of Michael Wasserman
Companies | Position | Start | End |
---|---|---|---|
Maverix Private Equity
Maverix Private Equity Investment ManagersFinance Maverix Private Equity (Maverix Private Equity) is a venture capital firm founded in 2019 by John Ruffolo and Mark G. Maybank. The firm is headquartered in Toronto, Canada. | Private Equity Investor | 01/05/2021 | 01/01/2024 |
Vertiflex, Inc.
Vertiflex, Inc. Medical SpecialtiesHealth Technology VertiFlex, Inc. operates as a medical device company. It offers minimally invasive solutions for the treatment of lumbar spinal stenosis (LSS), which is the cause of spinal surgery in the elderly. The firm specializes in minimally invasive, motion preservation, spine and medical device. The company was founded by Moti Altarac in 2005 and is headquartered in San Clemente, CA. | Director/Board Member | - | 18/06/2019 |
CELLutions Biosystems, Inc. | Founder | 01/01/2003 | 01/01/2004 |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Director/Board Member | - | - |
NeuWave Medical, Inc.
NeuWave Medical, Inc. Medical SpecialtiesHealth Technology NeuWave Medical, Inc. develops soft tissue ablation systems. Its products include 140 microwave ablation system which is used in surgeries. The company was founded by Fred T. Lee, Jr., Daniel van der Weid, Christopher Brace, and Paul F. Laeseke in 2004 and is headquartered in Madison, WI. | Director/Board Member | - | - |
Advanced Therapeutics of Wisconsin, Inc.
Advanced Therapeutics of Wisconsin, Inc. Finance/Rental/LeasingFinance Advanced Therapeutics of Wisconsin, Inc. provides hospital beds and related equipment leasing services. The company is headquartered in Muskego, WI. | Corporate Officer/Principal | - | - |
HyperBranch Medical Technology, Inc.
HyperBranch Medical Technology, Inc. Medical SpecialtiesHealth Technology HyperBranch Medical Technology, Inc. develops and markets biosurgical devices. It develops and markets products primarily for the traumatic or surgically induced wound market. The firm offers Adherus AutoSpray Dural Sealant which is a synthetic, absorbable, two-component dural sealant indicated for use in patients as an adjunct to standard methods of dural repair. The company was founded by Mark W. Grinstaff and Anthony J. Sherbondy in March 2003 and is headquartered in Durham, NC. | Director/Board Member | - | - |
Training of Michael Wasserman
McGill University | Undergraduate Degree |
University of Toronto | Doctorate Degree |
Statistics
International
United States | 7 |
Canada | 5 |
Operational
Director/Board Member | 4 |
Private Equity Investor | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 5 |
Finance | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 8 |
---|---|
HyperBranch Medical Technology, Inc.
HyperBranch Medical Technology, Inc. Medical SpecialtiesHealth Technology HyperBranch Medical Technology, Inc. develops and markets biosurgical devices. It develops and markets products primarily for the traumatic or surgically induced wound market. The firm offers Adherus AutoSpray Dural Sealant which is a synthetic, absorbable, two-component dural sealant indicated for use in patients as an adjunct to standard methods of dural repair. The company was founded by Mark W. Grinstaff and Anthony J. Sherbondy in March 2003 and is headquartered in Durham, NC. | Health Technology |
Vertiflex, Inc.
Vertiflex, Inc. Medical SpecialtiesHealth Technology VertiFlex, Inc. operates as a medical device company. It offers minimally invasive solutions for the treatment of lumbar spinal stenosis (LSS), which is the cause of spinal surgery in the elderly. The firm specializes in minimally invasive, motion preservation, spine and medical device. The company was founded by Moti Altarac in 2005 and is headquartered in San Clemente, CA. | Health Technology |
NeuWave Medical, Inc.
NeuWave Medical, Inc. Medical SpecialtiesHealth Technology NeuWave Medical, Inc. develops soft tissue ablation systems. Its products include 140 microwave ablation system which is used in surgeries. The company was founded by Fred T. Lee, Jr., Daniel van der Weid, Christopher Brace, and Paul F. Laeseke in 2004 and is headquartered in Madison, WI. | Health Technology |
Advanced Therapeutics of Wisconsin, Inc.
Advanced Therapeutics of Wisconsin, Inc. Finance/Rental/LeasingFinance Advanced Therapeutics of Wisconsin, Inc. provides hospital beds and related equipment leasing services. The company is headquartered in Muskego, WI. | Finance |
CELLutions Biosystems, Inc. | |
H.I.G. BioHealth Partners LLC
H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners LLC (H.I.G. BioHealth Partners) is a private equity and venture capital subsidiary of H.I.G. Ventures LLC founded in 1993. The firm is headquartered in Miami, Florida with additional offices around the globe. | Finance |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Health Technology |
Maverix Private Equity
Maverix Private Equity Investment ManagersFinance Maverix Private Equity (Maverix Private Equity) is a venture capital firm founded in 2019 by John Ruffolo and Mark G. Maybank. The firm is headquartered in Toronto, Canada. | Finance |
- Stock Market
- Insiders
- Michael Wasserman
- Experience